Cognitive impairments in patients with overweight and obesity

Background. In modern society, the growth of the overweight and obese population increase every year. This confirms the status assigned to the problem under consideration as a non-infectious epidemic of the 21st century. At the same time, the amount of scientific information about the influence of excess weight on various aspects of human life is actively increasing. This undoubtedly requires a systematic generalization of the available data.

Aims. The presented literature review is devoted to the analysis of modern scientific research on the specificity of cognitive impairment in overweight and obese people.

Materials and methods. Information search was carried out using Internet resources (PubMed, Web of Science, eLibrary.ru, frontiersin.org, sciencedirect. com, ncbi.nlm.nih.gov), literature sources were analyzed for the period from 2001 to 2020 for the following keywords: obesity, overweight, cognitive functions, cognitions, cognitive impairments.

Results. As a result of the literature review, the main directions of research on the relationship between cognitive impairment and overweight, as well as the relationship between cognitive dysfunction and obesity, were identified. The specificity of diametrically opposed opinions within the framework of each consecrated trend is presented. According to the results of the analysis of the identified areas, in the scientific community the most common point of view is the presence of a connection between obesity and cognitive impairment. In this connection, the authors identified the main cognitive impairments associated with excess weight and their mediating mechanisms. And also the age specificity of the problem under study is indicated.

Conclusions. Despite the fact that the problem of the relationship between obesity, overweight and cognitive functions is comprehensively studied, there is a shortage of data on the state of thinking, attention, praxis, gnosis, and speech in overweight people.

1. World Health Organization. Governments commit to advancements in dementia research and care. Available at: https://www.who.int/mediacentre/news/releases/2015/action-ondementia/en/ [Date of access: June 15, 2015]

2. Kolesnikova LI, Dolgih VV, Polyakov VM, Rychkova LV, Madaeva IM, Pogodina AV, et al. Psychophysiological relationships in arterial hypertension in ontogenesis. Byulleten’ SO RAMN. 2009; 5 (139): 79–85. (In Russ.)

3. Vizilo TL, Vizilo AD. Non-demented cognitive disorders: clinical aspects. Lechashchij vrach. 2019; 5: 10–12. (In Russ.)

4. Berdina ON, Rychkova LV, Madaeva IM. Sleep disorders and obesity in adolescents: features of the psycho-cognitive state (literature review). Acta biomedica scientifica. 2017; 2 (5): 93–98. doi: 10.12737/article_5a3a0e4a4bd9c6.35862127 (In Russ.)

5. World Health Organization. Obesity and overweight. Available at: https://www.who.int/news-room/factsheets/detail/obesity-and-overweight [Date of access: April 1, 2021]

6. RBK. Rosstat found overweight in three out of five Russians. Available at: https://www.rbc.ru/society/12/12/2019/5df209f59a79473d33ddd7c3 [date of access: December 12, 2019]. (In Russ.)

7. Dolgih VV, Klimkina YuN, Rychkova LV, Korovin SA. Epidemiological features of psychosomatic disorders on the example of obesity Acta Biomedica Scientifica. 2014; 4: 19–23. (In Russ.)

8. Palermo TM, Dowd JB. Childhood obesity and human capital accumulation. Social Science & Medicine. 2012; 75 (11): 1989–1998. doi: 10.1016/j.socscimed.2012.08.004

9. Bisset S, Fournier M, Pagani L, Janosz M. Predicting academic and cognitive outcomes from weight status trajectories during childhood. International Journal of Obesity. 2013; 37: 154–159. doi: 10.1038/ijo.2012.106

10. Li Y, Dai Q, Jackson JC, Zhang J. Overweight is associated with decreased cognitive functioning among school-age children and adolescents. Obesity. 2008; 16 (8): 1809–15. doi: 10.1038/oby.2008.296

11. Suhanov AV, Denisova DV. Association of body weight with the state of cognitive functions in adolescence: a population study. ZHurnal imeni GN Speranskogo. 2011; 90 (6): 26–28. (In Russ.)

12. Neznanov NG, Piotrovskaya VR, Vanaeva KI, et al. Results of screening assessment of cognitive functions in overweight individuals. Arterial’naya gipertenziya. 2011; 17 (2): 156–161. (In Russ.)

13. Novikova EA, Bairova TA, Rychkova LV. Association of the 48bp VNTR tandem repeat of the DRD4 gene with overweight/obesity (literature review). Acta biomedica scientifica. 2017; 2 (5): 63–68. doi: 10.12737/article_59e85bc95a4e77.95444674 (In Russ.)

14. Veena S, Hegde B, Ramachandraiah S, Krishnaveni G, Fall C, Srinivasan K. Relationship between adiposity and cognitive performance in 9–10 year old children in South India. Archives of disease in childhood. 2014; 99 (2): 126–134

15. Liang J, Matheson BE, Kaye WH, Boutelle K. Neurocognitive correlates of obesity and obesity-related behaviors in children and adolescents. Int J Obes (Lond). 2014; 38 (4): 494–506. doi: 10.1038/ijo.2013.142

16. Yeh TK, Cho YC, Yeh TC, Hu CY, Lee LC, Chang CY. An exploratory analysis of the relationship between cardiometabolic risk factors and cognitive/academic performance among adolescents. BioMed Research International. 2015; 2015: 1–9. doi: 10.1155/2015/520619

17. Cherian AT, Cherian SS, Subbiah S. Prevalence of obesity and overweight in urban school children in Kerala, India. Indian Pediatrics. 2012; 49 (6): 475–477. doi: 10.1007/s13312-012-0070-0

18. Leigh Gibson E, Green MW. Nutritional influences on cognitive function: mechanisms of susceptibility. Nutrition Research Reviews. 2002; 15 (01): 169–206. doi: 10.1079/nrr200131

19. Deckers K, van Boxtel MPJ, Verhey FRJ, Köhler S. Obesity and cognitive decline in adults: Effect of methodological choices and confounding by age in a longitudinal study. The journal of nutrition, health & aging. 2017; 21 (5): 546–553. doi:10.1007/s12603-016-0757-3

20. Kolesnikov SI, Kolesnikova LI, Dolgih VV, et al. The functional activity of the brain and the processes of lipid peroxidation in children during the formation of psychosomatic disorders. Novosibirskoe otdelenie izdatel’stva «Nauka». 2008: 199. (In Russ.)

21. Rychkova LV, Ayurova ZhG, Pogodina AV, Kosovceva AS. Risk factors for the development of obesity in adolescents of ethnic groups in rural areas of the Republic of Buryatia: results of a cross-sectional study. Voprosy sovremennoj pediatrii. 2017; 16 (6): 509–515. (In Russ.)

22. Ling C, Rönn T. Epigenetics in Human Obesity and Type 2 Diabetes. Cell Metabolism. 2019; 29 (5): 1028–1044. doi: 10.1016/j.cmet.2019.03.009

23. Argueta DA, DiPatrizio NV. Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity. Physiology & Behavior. 2017; 171: 32–39. doi: 10.1016/j.physbeh.2016.12.044

24. Yaffe K, Weston AL, Blackwell T, Krueger KA. The metabolic syndrome and development of cognitive impairment among older women. Archives of Neurology. 2009; 66 (3): 324–328. doi: 10.1001/archneurol. 2008.566

25. Zeki Al, Hazzouri A, Haan MN, Whitmer RA, Yaffe K, Neuhaus J. Central obesity, leptin and cognitive decline: the Sacramento Area Latino Study on Aging. Dementia and Geriatric Cognitive Disorders. 2012; 33 (6): 400–409. doi: 10.1159/000339957

26. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005; 330 (7504): 1360–1364. doi: 10.1136/bmj.38446.466238.E0

27. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease. Archives of Internal Medicine. 2003; 163 (13): 1524–1528. doi: 10.1001/archinte.163.13.1524

28. Ying-Xiu Z, Shu-Rong W. Secular trends in body mass index and the prevalence of overweight and obesity among children and adolescents in Shandong, China, from 1985 to 2010. Journal of Public Health. 2012; 34 (1): 131–137. doi: 10.1093/pubmed/fdr053

29. Dahl A, Hassing LB, Fransson E, et al. Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2010; 65A (1). doi: 10.1093/gerona/glp035

30. Tanashyan MM, Lagoda OV, Orlov SV et al. Vascular diseases of the brain and metabolic syndrome. Terapevticheskij arhiv. 2013; 85 (10): 34–42. (In Russ.)

31. Zueva IB, Vanaeva KI, SHlyahto EV. Cognitive impairment in obese patients. Role of endogenous cannabinoids. Arterial’naya gipertenziya. 2012; 18 (2): 126–135. doi: 10.18705/1607-419X-2012-18-2-126-135 (In Russ.)

32. Zueva IB, Vanaeva KI. Endogenous cannabinoids and cognitive function in obese patients. Sibirskij nauchnyj medicinskij zhurnal. 2012; 32 (5): 63–68. (In Russ.)

33. Berdina ON, Madaeva IM, Rychkova LV. Obesity and disturbances in circadian rhythms of sleep and wakefulness: points of contact and prospects for therapy. Acta Biomedica Scientifica (East Siberian Biomedical Journal). 2020; 5 (1): 21–30. doi:10.29413/ABS.2020–5.1.3 (In Russ.)

34. Shevyrtalova ON, Protopopova ON, Madaeva IM, et al. Sleep disorders in the genesis of emotional, personality and cognitive disorders in adolescents with essential arterial hypertension. Rossijskij pediatricheskij zhurnal. 2011; 2: 12–16. (In Russ.)

35. Lisovskaya NA, Dubinina EA, Antonova TD, et al. Obstructive sleep apnea syndrome in overweight and obese adolescents: a focus on cognitive functioning. Arterial’naya gipertenziya. 2017; 23 (4): 303–312. doi: 10.18705/1607-419X-2017-23-4-303-312 (In Russ.)

36. Dubina EA, Rotar’ OP, Moguchaya EV, et al. Metabolic syndrome and cognitive dysfunction in the elderly: women at risk. Arterial’naya gipertenziya. 2014; 20 (4): 238–248. (In Russ.)

37. Morley JE, Banks WA. Lipids and Cognition. Journal of Alzheimer’s Disease. 2010; 20 (3). doi: 10.3233/JAD-2010–091576

38. Efimova NYu, CHernov VI, Efimova (Shvera) IYu, Idrisova EM, Pavlyukova EN, Lishmanov YuB. The role of endothelial dysfunction in the mechanism of the development of cognitive impairment in patients with metabolic syndrome. Sibirskij vestnik psihiatrii i narkologii. 2010; 2 (59): 85–89. (In Russ.)

39. Puig J, Blasco G, Daunis-i-Estadella J, et al. Hypothalamic damage is associated with inflammatory markers and worse cognitive performance in obese subjects. The Journal of Clinical Endocrinology & Metabolism. 2015; 100 (2). doi: 10.1210/jc.2014-2682

40. Ivleva AYa, Burkov SG. Overweight and obesity is a medical problem, not a cosmetic one. Ozhirenie i metabolizm. 2010; 7 (3): 15–19. doi: 10.14341/2071-8713-4978 (In Russ.)

41. Rapoport SI, Loboda AYu. Obesity problem in the clinic of internal medicine. Klinicheskaya medicina. 2008; 11: 15–23. (In Russ.)

42. Mel’nichenko GA, Romancova TI. Obesity: epidemiology, classification, pathogenesis, clinical symptoms and diagnosis. Dedov II, Mel’nichenko GA (ed.) Obesity. Etiology, Pathogenesis, Clinical Aspects: A Guide for Physicians. MIA. 2004; 16–42. (In Russ.)

43. Bermudez-Silva FJ, Cardinal P, Cota D. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. Journal of Psychopharmacology. 2012; 26 (1): 114–24. doi: 10.1177/0269881111408458

44. Gray J, Yeo G, Hung C, et al. Functional characterization of human NTRK2 mutations identified in patients with severe earlyonset obesity. International Journal of Obesity. 2007; 31: 359–364. doi: 10.1038/sj.ijo.0803390

45. Shishkova VN. Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention. Terapevticheskii arkhiv. 2015; 87 (1): 109–114. doi: 10.17116/terarkh2015871109-114 (In Russ.)

46. Dorrance A, Matin N, Pires P. The Effects of Obesity on the Cerebral Vasculature. Current Vascular Pharmacology. 2014; 12 (3): 462–472. doi: 10.2174/1570161112666140423222411

47. Kolesnikova LI, Darenskaya MA, Kolesnikov SI. Free radical oxidation: a pathophysiologist’s view. Byulleten’ sibirskoj mediciny. 2017; 16 (4): 16–29. doi: 10.20538/1682-0363-2017-4-16-29

48. Yeo GSH, Connie Hung C–C, Rochford J, et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nature Neuroscience. 2004; 7: 1187–1189. doi: 10.1038/nn1336

49. Gray J, Yeo GSH, Cox JJ, et al. Hyperphagia, Severe Obesity, Impaired Cognitive Function, and Hyperactivity Associated With Functional Loss of One Copy of the Brain-Derived Neurotrophic Factor (BDNF) Gene. Diabetes. 2006; 55 (12): 3366–3371. doi: 10.2337/db06-0550

50. Bonnefond A, Raimondo A, Stutzmann F, et al. Loss-offunction mutations in SIM1 contribute to obesity and PraderWilli – like features. Journal of Clinical Investigation. 2013; 123: 3037–3041. doi: 10.1172/JCI68035

51. Benedict C, Jacobsson JA, Rönnemaa E, et al. The fat mass and obesity gene is linked to reduced verbal fluency in overweight and obese elderly men. Neurobiology of Aging. 2011; 32 (6): 1159. e1–5. doi: 10.1016/j.neurobiolaging.2011.02.006

52. Ronan L, Alexander-Bloch A, Fletcher PC. Childhood Obesity, Cortical Structure, and Executive Function in Healthy Children. Cerebral Cortex. 2020; 30 (4): 2519–2528. doi: 10.1093/cercor/bhz257

53. Folch J, Pedrós I, Patraca I, et al. Neuroprotective and anti-ageing role of leptin. Journal of Molecular Endocrinology. 2012; 49 (3): R149–156. doi: 10.1530/JME-12–0151

54. Li X–L, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience. 2002; 113 (3): 607–615. doi: 10.1016/S0306-4522(02)00162-8

55. Matveeva MV, Samojlova YuG, ZHukova NG. Obesity and Cognitive Dysfunction. Ozhirenie i metabolizm. 2016; 13 (3): 3–8. doi: 10.14341/omet201633-8 (In Russ.)

56. Cetinkalp S, Simsir I, Ertek S. Insulin Resistance in Brain and Possible Therapeutic Approaches. Current Vascular Pharmacology. 2014; 12 (4): 553–564. doi: 10.2174/1570161112999140206130426

57. Pratchayasakul W, Sanguanmoo P, Sivasinprasasn S, et al. Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions. Hormones and Behavior. 2015; 72: 68–77. doi: 10.1016/j.yhbeh.2015.04.023

58. Wang J, Freire D, Knable L, et al. Childhood and adolescent obesity and long-term cognitive consequences during aging. Journal of Comparative Neurology. 2015; 523 (5): 757–768. doi: 10.1002/cne.23708

59. Miller AA, Spencer SJ. Obesity and neuroinflammation: A pathway to cognitive impairment. Brain, Behavior, and Immunity. 2014; 42: 10–21. doi: 10.1016/j.bbi.2014.04.001

60. Stranahan AM. Models and mechanisms for hippocampal dysfunction in obesity and diabetes. Neuroscience. 2015; 309: 125–139. doi: 10.1016/j.neuroscience.2015.04.045

61. Schrijvers EMC, Witteman JCM, Sijbrands EJG, Hofman A, Koudstaal PJ, Breteler MMB. Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study. Neurology. 2010; 75 (22): 1982–1987. doi: 10.1212/WNL.0b013e3181ffe4f6

62. Awad N, Gagnon M, Messier C. The Relationship between Impaired Glucose Tolerance, Type 2 Diabetes, and Cognitive Function. Journal of Clinical and Experimental Neuropsychology. 2004; 26 (8): 443–454. doi: 10.1080/13803390490514875

63. Sabia S, Kivimaki M, Shipley M, Marmot M, SinghManoux A. Body mass index over the adult life course and cognition in late midlife: The Whitehall II Cohort Study. American journal of clinical nutrition. 2009; 89 (2): 601–607. doi: 10.3945/ajcn.2008.26482

64. Ramachandrappa S, Raimondo A, Cali AMG, et al. Rare variants in single-minded 1 (SIM1) are associated with severe obesity. Journal of Clinical Investigation. 2013; 123: 3042–3050. doi: 10.1172/JCI68016

65. Lahiri D, Zawia N, Greig N, Sambamurti K, Maloney B. Earlylife events may trigger biochemical pathways for Alzheimer’s disease: the «LEARn» model. Biogerontology. 2008; 9: 375–379. doi: 10.1007/s10522-008-9162-6

66. Breteler M. Early life circumstances and late life Alzheimer’s disease. Epidemiology. 2001; 12 (4): 378–379

67. Mihaleva OG, Bardymova TP, Berezina MV. Monogenic forms of obesity. Sibirskij medicinskij zhurnal. 2014; 129 (6): 5–11. (In Russ.)

68. Spyridaki EC, Simos P, Avgoustinaki PD, et al. The association between obesity and fluid intelligence impairment is mediated by chronic low-grade inflammation. British Journal of Nutrition. 2014; 112 (10): 1724–1734. doi: 10.1017/S0007114514002207

69. Thaler JP, Yi C–X, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. Journal of Clinical Investigation. 2012; 122 (1): 153–162. doi: 10.1172/JCI59660

70. Piotrovskaya VR, Monosova KI. Joint participation of the metabolic syndrome and the endocannabinoid system in the development of affective non-psychotic mental disorders and cognitive deficits in obese middle-aged people. In: Materials of the All-Russian Scientific-Practical. Conf. with Int. Participation: Psychiatry in the Stages of Reforms: Problems and Prospects. 2015: 743–744. (In Russ.)

71. Bolzenius JD, Laidlaw DH, Cabeen RP, et al. Brain structure and cognitive correlates of body mass index in healthy older adults. Behavioural Brain Research. 2015; 278: 342–347. doi: 10.1016/j.bbr.2014.10.010